Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05826444

Microvascular Cardiac Allograft Vasculopathy Trial

Morphological and Functional Phenotype of Isolated Microvascular Cardiac Allograft Vasculopathy in Heart Transplant Recipients

Status
Recruiting
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
German Heart Institute · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The aim of the mCAV study is a comprehensive characterization of the genetic, morphological and functional phenotype of isolated microvascular graft vasculopathy (mCAV) after orthotopic heart transplantation (OHT). The utilized methods include dynamic echocardiography, magnetic resonance imaging, invasive microvascular resistance measurements, histology, cellular calcium-signaling and magnetocardiography as well as molecular genetic expression analysis (miRNA based).

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTEchocardiographyEchocardiography with afterload change
DIAGNOSTIC_TESTMagnetic resonance imagingStress-MRI
DIAGNOSTIC_TESTMagnetocardiographyMagnetocardiography
DIAGNOSTIC_TESTHistologyHistological analysis
DIAGNOSTIC_TESTGeneticsmiRNA sequencing
DIAGNOSTIC_TESTcalcium signalingcardiomyocyte calcium signaling
DIAGNOSTIC_TESTIMRIndex of microvascular resistance measurement
DIAGNOSTIC_TESTAngio-IMRAngiography derived post-processing index if microvascular resistance

Timeline

Start date
2022-10-01
Primary completion
2025-12-31
Completion
2025-12-31
First posted
2023-04-24
Last updated
2024-08-12

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT05826444. Inclusion in this directory is not an endorsement.